Siscapa Assay Technologies Inc. (SAT)

https://www.siscapa.com

SISCAPA Assay Technologies is focused on creating SISCAPA® assays for a growing menu of high-value protein biomarkers, with the long-term goal of enabling sensitive and precise measurement of every human protein in clinical and other samples. Additional information about SISCAPA affinity-MS technology, available reagents, and licensing opportunities is available at www.SISCAPA.com. *

	Start	2011-06-15 existent
	Industry	SISCAPA® assay (Stable Isotope Standards and Capture by Anti-Peptide Antibodies)
	Industry 2	mass spectrometry technology
	Person	Salem, Gustavo (Gus) (IDEX 201605 Group President of IDEX Health & Science before Siscapa + Agilent + Assay Designs)
	Person 2	Anderson, N. Leigh (Plasma Proteome Institute 200808 + SCISCAPA Assay Technologies)

	Region	Rockville, MD
	Country	United States (USA)
	City	n. a. Rockville, MD
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2025-05-22

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Siscapa Assay Technologies Inc. (SAT)

[1] Biognosys AG. (5/19/25). "Press Release: Siscapa and Biognosys Announce Strategic Collaboration to Deliver End-to-End High-Sensitivity Targeted Protein Quantification Solutions". Washington, DC & Zurich....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com